References
Pisco JM, Bilhim T, Costa NV, Torres D, Pisco J, Pinheiro LC, Oliveira AG. Randomised clinical trial of prostatic artery embolisation versus a sham procedure for benign prostatic hyperplasia. Eur Urol. 2020;77(3):354–62.
Davis C, Golzarian J, White S, Fischman A, Rastinehad A, Isaacson A, Carnevale FC, Foster H Jr, Findeiss L, Sapoval M, Borofsky M, Ayyagari R, Salem R, Bhatia S, Caridi T. Development of research agenda in prostate artery embolization: summary of society of interventional radiology consensus panel. J Vasc Interv Radiol. 2020;31(1):108–13.
Speakman MJ, Cornu JN, Gacci M, Gratzke C, Mamoulakis C, Herrmann TRW, Omar MI, Rieken M, Tikkinen KAO, Gravas S. What is the required certainty of evidence or the implementation of novel techniques for the treatment of benign prostatic obstruction? Eur Urol Focus. 2019;5(3):351–6.
Abt D, Schmid HP, Müllhaupt G. Prostatic artery embolization: a curse or a blessing? Eur Urol. 2020;77(3):363–4. https://doi.org/10.1016/j.eururo.2019.11.031.
Revicki D, Hays RD, Cella D, Sloan J. Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol. 2008;61(2):102–9.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Marc Sapoval is a consultant to Merit Medical.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Sapoval, M., Sabharwal, T. More Evidence Support PAE: Results of Sham Comparison. Cardiovasc Intervent Radiol 43, 1738–1739 (2020). https://doi.org/10.1007/s00270-020-02513-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00270-020-02513-6